OMICS Publishing Group, Journal of Nanomedicine & Biotherapeutic Discovery (JNBD) is an international, peer-reviewed journal. Each issue of Journal of Nanomedicine & Biotherapeutic Discovery presents basic, clinical, and engineering research in the field of nanomedicine and the related biotherapeutic discovery. The regular features addresses the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians.

1. Journal of Nanomedicine
& Biotherapeutic
Discovery

2. Open Access
 Open Access is a means to provide access to the scientific literature to
anyone with no charge to the user. Thus, anyone may access the
information, and use that material for scholarship, teaching or personal
investigation.
 There are more than 6,000 OA journals listed in the directory of open
access journals (DOAJ), and implied that the number of Open Access
articles is now growing more and more quickly than the number of papers
being published in subscription journals.

3. Benefits of Open Access
(Online Publishing)
• Wide spread availability of the work
• The ability to widen the circle with links
• Long-term availability of the work online
• Faster response time
• Maximized exposure through the media capability
• Increase in the no. of citations

4. Main Aim of the Journal
To publish the most exciting researches with respect to the subjects of
Nanomedicine & Biotherapeutics
It cover the most current and controversial topics and the Contents
include peer-reviewed research reports on all aspects of
Nanotechnology, critical reviews, commentaries, factors involved in
treatment of diseases in various fields .
To disseminate the articles freely for research, teaching and reference
purposes.

5. Scope of the Journal
Journal of Nanomedicine & Biotherapeutic Disocvery is an
international, peer-reviewed journal covering all the aspects in
treatment of diseases using the nanoparticles
The journal welcomes original research, reviews, abstracts, case
reports, conference proceedings and short communications related to
Nanomedicine.

6. Issue Release- Year Wise
7
6
6
5
5
4 4 4 4
4
3 2011
3
2012
2
1
0
Issue 1 Issue 2 Issue 3 Issue 4 Issue 5

7. EB Members based on classification
EB Members
Nanobiology : Nanomedicine
5 :11 Nanomedicine
Cancer
Treatment :15 Nanotechnology
Nanotech:9
Signal Transduction
Chemotherapy Signal Chemotherapy
: 12 Transduction8
Cancer Treatment
Nanobiology

8. Editor-in-Chief & Executive Editor Details
Editor-in-Chief
Fatih M. Uckun,
Kansas State University, USA
Executive Editors
Julia Y. Ljubimova,
Cedars-Sinai Medical Center,USA
Hai-Feng Frank JI,
Drexel University,USA

9. Related Conference in OMICS
Previous Conferences: 2nd International Conference and Exhibition on
Nanotek & Expo, March 03-05, 2012 Double Tree by Hilton Philadelphia
Center City, USA
Upcoming Conferences: : 3rd International Conference and Exhibition on
Nanotek & Expo, March 03-05, 2013 Double Tree by Hilton Philadelphia
Center City, USA

10. Journal Indexed in